Literature DB >> 19948560

TGFBI mutational analysis in a New Zealand population of inherited corneal dystrophy patients.

Andrea L Vincent1, Betina de Karolyi, Dipika V Patel, Catherine E Wheeldon, Charles N J McGhee.   

Abstract

AIM: The corneal dystrophies represent a group of clinically and genetically heterogeneous, inherited diseases, often resulting in bilateral opacification of the cornea, and may require penetrating keratoplasty. Mutations in the transforming growth factor beta-induced (TGFBI) gene segregate with a wide range of phenotypically heterogeneous corneal dystrophies. Many of the other dystrophies remain without molecular characterisation. This study aimed to characterise the molecular basis for corneal disease in a New Zealand population.
METHODS: Nineteen unrelated individuals affected with a corneal dystrophy (granular, fleck, lattice, posterior polymorphous) and their family members were recruited, a pedigree obtained and their dystrophy extensively phenotyped. After informed consent, samples were taken for DNA extraction. PCR and sequencing of all coding exons of TGFBI was undertaken.
RESULTS: All five patients with granular dystrophy had the R555W mutation, and H626P was identified in an intermediate dystrophy of Bowman layer pedigree. No other mutations were detected including in the stromal dystrophy cases.
CONCLUSION: Mutational analysis of TGFBI in a small population has identified sequence changes consistent with previously identified genotype-phenotype correlations. A new genotype-phenotype association was also characterised. No mutations were identified in some individuals/pedigrees suggesting greater genetic heterogeneity than is currently known in this group of disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19948560     DOI: 10.1136/bjo.2009.159632

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  A recognition survey of granular corneal dystrophy type 2 genetic detection in China.

Authors:  Xin-Rui Wang; Bi-Ting Zhou; Qing-Mei Zheng; Ya-Duan Wang; Qiu-Kai Huang; Xuan Song; He Wang; Nan-Wen Zhang; Yi-Hua Zhu; Xiao-Le Chen; Ju-Hua Yang
Journal:  Int J Ophthalmol       Date:  2020-12-18       Impact factor: 1.779

2.  TGFBI gene mutations in a Korean population with corneal dystrophy.

Authors:  Kyong Jin Cho; Jee Won Mok; Kyung Sun Na; Chang Rae Rho; Yong Soo Byun; Ho Sik Hwang; Kyu Yeon Hwang; Choun-Ki Joo
Journal:  Mol Vis       Date:  2012-07-20       Impact factor: 2.367

3.  TGFBI mutation screening and genotype-phenotype correlation in north Indian patients with corneal dystrophies.

Authors:  Preeti Paliwal; Arundhati Sharma; Radhika Tandon; Namrata Sharma; Jeewan S Titiyal; Seema Sen; Punit Kaur; Divya Dube; Rasik B Vajpayee
Journal:  Mol Vis       Date:  2010-07-29       Impact factor: 2.367

4.  The TGFBI R555W mutation induces a new granular corneal dystrophy type I phenotype.

Authors:  Yanan Zhu; Xingchao Shentu; Wei Wang
Journal:  Mol Vis       Date:  2011-01-20       Impact factor: 2.367

5.  Phenotype-genotype correlations in patients with TGFBI-linked corneal dystrophies in Taiwan.

Authors:  Yu-Chih Hou; I-Jong Wang; Cheng-Hsiang Hsiao; Wei-Li Chen; Fung-Rong Hu
Journal:  Mol Vis       Date:  2012-02-07       Impact factor: 2.367

6.  Mutation Analysis of the TGFBI Gene in Consecutive Korean Patients With Corneal Dystrophies.

Authors:  Ju Sun Song; Dong Hui Lim; Eui-Sang Chung; Tae-Young Chung; Chang-Seok Ki
Journal:  Ann Lab Med       Date:  2015-04-01       Impact factor: 3.464

7.  Genetic analysis of CHST6 and TGFBI in Turkish patients with corneal dystrophies: Five novel variations in CHST6.

Authors:  Fulya Yaylacioglu Tuncay; Gülsüm Kayman Kurekci; Sezen Guntekin Ergun; Ozge Tugce Pasaoglu; Rustu Fikret Akata; Pervin Rukiye Dincer
Journal:  Mol Vis       Date:  2016-10-26       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.